RACHEL RACKARD
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- MOUNDVILLE, AL
- NPI
- 1306171236
- Received
- $3,402 in 169 records, 2020 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 36 | $714 |
| 2024 | General payment | 33 | $646 |
| 2023 | General payment | 35 | $722 |
| 2022 | General payment | 27 | $510 |
| 2021 | General payment | 24 | $439 |
| 2020 | General payment | 14 | $369 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 30 | $594 | 2021–2025 |
| Novo Nordisk Inc | 22 | $527 | 2020–2025 |
| Vanda Pharmaceuticals Inc. | 20 | $442 | 2020–2023 |
| Corium, LLC | 15 | $352 | 2023–2025 |
| GlaxoSmithKline, LLC. | 13 | $221 | 2021–2025 |
| Janssen Pharmaceuticals, Inc | 9 | $196 | 2022–2023 |
| AstraZeneca Pharmaceuticals LP | 11 | $192 | 2020–2025 |
| Alkermes, Inc. | 10 | $168 | 2021–2023 |
| Lilly USA, LLC | 7 | $128 | 2024–2025 |
| Otsuka America Pharmaceutical, Inc. | 6 | $89 | 2020–2023 |
| Novartis Pharmaceuticals Corporation | 3 | $67 | 2025 |
| IRONSHORE PHARMACEUTICALS INC. | 3 | $67 | 2023–2024 |
| PFIZER INC. | 3 | $51 | 2020–2023 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 | 2024 |
| Lundbeck LLC | 2 | $40 | 2024–2025 |
| Exact Sciences Corporation | 2 | $31 | 2024–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 | 2025 |
| Neurocrine BioSciences, Inc. | 1 | $23 | 2024 |
| Esperion Therapeutics, Inc. | 1 | $21 | 2021 |
| Tris Pharma Inc | 1 | $20 | 2023 |
| Collegium Pharmaceutical, Inc. | 1 | $19 | 2025 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 | 2021 |
| Axsome Therapeutics, Inc. | 1 | $14 | 2024 |
| Noven Therapeutics, LLC | 1 | $14 | 2024 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $13 | 2024 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 169 | $3,402 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | Corium, LLC | $20 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2025 | |
| 2025-11-18 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-11-10 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | Lundbeck LLC | $22 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-04 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-10-30 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-21 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-10-16 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-10-13 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-06 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-20 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-09-07 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-08-18 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-14 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-08-05 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-07-21 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-14 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-13 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-09 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-29 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-05-16 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-05-15 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-15 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-05-14 | Novo Nordisk Inc | $24 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-12 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-29 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-04-24 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-16 | Collegium Pharmaceutical, Inc. | $19 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-04-14 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-28 | Exact Sciences Corporation | $16 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2025 | |
| 2025-03-25 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-20 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-02-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-03 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-01-28 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-11-12 | Axsome Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-10-29 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-10-28 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-19 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-17 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-09-20 | Novo Nordisk Inc | $25 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-19 | Corium, LLC | $24 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-09-17 | IRONSHORE PHARMACEUTICALS INC. | $19 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-08-29 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-28 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-08-27 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-08-08 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-05 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-07-12 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-06-24 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-06-04 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-06-03 | Corium, LLC | $23 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-05-20 | Exact Sciences Corporation | $14 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-05-16 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-10 | Novo Nordisk Inc | $24 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-05-10 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-04-24 | Noven Therapeutics, LLC | $14 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-03-27 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-03-14 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-03-12 | Corium, LLC | $20 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-02-29 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-02-28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-02-27 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-26 | Corium, LLC | $21 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-02-15 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-01-29 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-10 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-05 | Corium, LLC | $25 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2023-12-08 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-12-05 | Novo Nordisk Inc | $24 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-12-02 | IRONSHORE PHARMACEUTICALS INC. | $24 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2023 | |
| 2023-11-30 | Corium, LLC | $25 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-11-30 | Tris Pharma Inc | $20 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-11-09 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-10-26 | Corium, LLC | $24 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-10-14 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-10-12 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-04 | IRONSHORE PHARMACEUTICALS INC. | $22 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2023 | |
| 2023-09-25 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-09-21 | Corium, LLC | $21 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-09-20 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2023 | |
| 2023-09-08 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-09-01 | Corium, LLC | $28 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-08-15 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-08-04 | Corium, LLC | $21 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-07-24 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-07-01 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-06-29 | Corium, LLC | $21 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-06-06 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-30 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-05-17 | Janssen Pharmaceuticals, Inc | $25 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-05-16 | Corium, LLC | $26 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-05-09 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2023 | |
| 2023-04-11 | Corium, LLC | $30 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-04-11 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-03-01 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2023 | |
| 2023-02-16 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-02-14 | Janssen Pharmaceuticals, Inc | $27 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-02-14 | Corium, LLC | $17 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-02-09 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-31 | Vanda Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2023 | |
| 2023-01-30 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-01-16 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2022-12-06 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-12-02 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-11-29 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-11-15 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-11-02 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-11-01 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-19 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-10-18 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-10-13 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2022 | |
| 2022-10-12 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-09-28 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-09-26 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-08-26 | Janssen Pharmaceuticals, Inc | $25 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-08-23 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-08-22 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2022 | |
| 2022-08-02 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-07-31 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-06-01 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-05-23 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Tresiba Drug, Diabetes | 2022 | |
| 2022-05-17 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-12 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-05 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-03-10 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-03-03 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2022 | |
| 2022-02-28 | Janssen Pharmaceuticals, Inc | $22 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-02-15 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-02-07 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2021-11-05 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-09-28 | Alkermes, Inc. | $12 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-09-14 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-09-07 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-01 | GlaxoSmithKline, LLC. | $11 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2021 | |
| 2021-08-24 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-08-19 | Takeda Pharmaceuticals U.S.A., Inc. | $12 | Food and Beverage | In-kind items and services | VYVANSE Drug, NEUROSCIENCE | 2021 | |
| 2021-08-17 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-08-03 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-07-27 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-07-06 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-06-08 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-06-07 | Vanda Pharmaceuticals Inc. | $31 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-06-01 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-06-01 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-04-20 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-04-16 | Esperion Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | NEXLETOL Drug, ANTILIPEMIC AGENTS | 2021 | |
| 2021-04-13 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-04-06 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-03-30 | Vanda Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-03-09 | Vanda Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-02-02 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-01-12 | Vanda Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-01-05 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2020-12-08 | Vanda Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2020 | |
| 2020-11-24 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2020 | |
| 2020-11-17 | Vanda Pharmaceuticals Inc. | $28 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2020 | |
| 2020-11-16 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | COLOGUARD Device, GASTROINTESTINAL | 2020 | |
| 2020-10-28 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2020 | |
| 2020-10-28 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2020 | |
| 2020-10-20 | Novo Nordisk Inc | $117 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2020 | |
| 2020-10-20 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2020 | |
| 2020-10-13 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | COLOGUARD Device, GASTROINTESTINAL | 2020 | |
| 2020-10-06 | Vanda Pharmaceuticals Inc. | $32 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2020 | |
| 2020-09-25 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2020 | |
| 2020-09-08 | Vanda Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2020 | |
| 2020-08-20 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2020 | |
| 2020-08-04 | Vanda Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Moundville, AL, county Hale County, AL, state Alabama; placed by its city name.
| Measure | Place (city or town) Moundville, AL | County Hale County, AL | State Alabama |
|---|---|---|---|
| Population B01003 | 3,754 | 14,829 | 5,086,768 |
| Population, 2020 census P1 | 3,024 | 14,785 | 5,024,279 |
| Median age B01002 | 32.8 | 40.6 | 39.3 |
| Under 18 B01001 | 27.7% | 24.2% | 22.2% |
| 65 and over B01001 | 7.0% | 20.0% | 17.8% |
| Households B11001 | 1,117 | 5,642 | 1,997,247 |
| Foreign born B05002 | 1.9% | 0.8% | 4.0% |
| Median household income B19013 | $73,036 | $39,250 | $63,999 |
| Median family income B19113 | $84,421 | $65,653 | $83,032 |
| Per capita income B19301 | $27,381 | $26,491 | $36,087 |
| Poverty rate B17001 | 17.6% | 24.6% | 15.6% |
| Unemployment rate B23025 | 2.2% | 6.0% | 4.7% |
| Civilian labor force B23025 | 1,619 | 5,635 | 2,367,787 |
| Mean commute (minutes) B08013 | 26.0 | 30.2 | 25.5 |
| Bachelor's degree or higher B15003 | 21.0% | 17.6% | 28.4% |
| Housing units B25001 | 1,153 | 7,594 | 2,337,265 |
| Owner-occupied B25003 | 79.3% | 74.4% | 70.2% |
| Renters B25003 | 20.7% | 25.6% | 29.8% |
| Median home value B25077 | $189,700 | $127,600 | $209,900 |
| Median gross rent B25064 | $798 | $715 | $1,007 |
| White, not Hispanic B03002 | 40.4% | 38.1% | 63.4% |
| Black B03002 | 45.8% | 54.6% | 25.6% |
| Hispanic or Latino B03002 | 2.9% | 1.3% | 5.6% |
| Asian B03002 | 0.0% | 0.1% | 1.4% |
| American Indian and Alaska Native B03002 | 0.0% | 0.4% | 0.3% |
Economy now FRED unemployment 3.5% in Sep 2026 (2.8% a year earlier); per capita personal income $59,754 in 2025, up 30% in five years (+4.7% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Moundville, AL.
Comments